From mboxrd@z Thu Jan 1 00:00:00 1970 Return-Path: Received: (qmail 7016 invoked by alias); 13 Jul 2006 18:05:38 -0000 Received: (qmail 6878 invoked by uid 22791); 13 Jul 2006 18:05:36 -0000 X-Spam-Check-By: sourceware.org Received: from main.gmane.org (HELO ciao.gmane.org) (80.91.229.2) by sourceware.org (qpsmtpd/0.31) with ESMTP; Thu, 13 Jul 2006 18:05:34 +0000 Received: from list by ciao.gmane.org with local (Exim 4.43) id 1G15Yl-0002r9-57 for cygwin-talk@cygwin.com; Thu, 13 Jul 2006 20:05:11 +0200 Received: from 65.207.213.226 ([65.207.213.226]) by main.gmane.org with esmtp (Gmexim 0.1 (Debian)) id 1AlnuQ-0007hv-00 for ; Thu, 13 Jul 2006 20:05:11 +0200 Received: from mwoehlke by 65.207.213.226 with local (Gmexim 0.1 (Debian)) id 1AlnuQ-0007hv-00 for ; Thu, 13 Jul 2006 20:05:11 +0200 To: cygwin-talk@cygwin.com From: mwoehlke Subject: Re: spotting cygwin ml trends Date: Thu, 13 Jul 2006 18:05:00 -0000 Message-ID: References: <20060713170140.GA6736@trixie.casa.cgf.cx> Mime-Version: 1.0 Content-Type: text/plain; charset=ISO-8859-1; format=flowed Content-Transfer-Encoding: 7bit User-Agent: Thunderbird 1.5.0.4 (X11/20060516) In-Reply-To: <20060713170140.GA6736@trixie.casa.cgf.cx> X-IsSubscribed: yes Mailing-List: contact cygwin-talk-help@cygwin.com; run by ezmlm Precedence: bulk List-Subscribe: List-Post: List-Help: , Sender: cygwin-talk-owner@cygwin.com Reply-To: The Cygwin-Talk Maiming List X-SW-Source: 2006-q3/txt/msg00024.txt.bz2 Christopher Faylor wrote: > It seems like this type of email is on the rise: > > " is > since I last updated Cygwin." > > > > "Oh, I found the problem. I had previously done hard-to-forget thing>. When I reverted that, things started working > fine." > > I wonder if that's a sign of anything. It might mean that there is an > increase in people/organizations using cygwin and they are including > stupid instructions to work around real or imagined problems. There is *NEVER* a shortage of stupid people doing stupid things. :-) -- Matthew Warning: This message has not been approved by the FDA.